UBS Group AG - ONCOLYTICS BIOTECH INC ownership

ONCOLYTICS BIOTECH INC's ticker is ONCY and the CUSIP is 682310875. A total of 37 filers reported holding ONCOLYTICS BIOTECH INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ONCOLYTICS BIOTECH INC
ValueSharesWeighting
Q3 2023$16,709
-52.2%
7,665
-43.0%
0.00%
Q2 2023$34,980
+218.6%
13,454
+47.0%
0.00%
Q1 2023$10,979
-12.1%
9,150
+19.4%
0.00%
Q4 2022$12,495
+38.8%
7,6650.0%0.00%
Q3 2022$9,000
-18.2%
7,665
-25.0%
0.00%
Q2 2022$11,00010,223
+6095.8%
0.00%
Q1 2022$0
-100.0%
165
-95.0%
0.00%
Q4 2021$4,000
-92.9%
3,305
-87.7%
0.00%
Q3 2021$56,000
-1.8%
26,790
+29.5%
0.00%
Q2 2021$57,000
+612.5%
20,689
+879.6%
0.00%
Q1 2021$8,0002,112
+1187.8%
0.00%
Q4 2020$01640.0%0.00%
Q3 2020$01640.0%0.00%
Q2 2020$0
-100.0%
164
-78.0%
0.00%
Q1 2020$1,000
-92.9%
744
-75.2%
0.00%
Q4 2019$14,0003,000
+303.2%
0.00%
Q3 2019$0
-100.0%
7440.0%0.00%
Q2 2019$1,0000.0%744
+7.5%
0.00%
Q1 2019$1,0000.0%692
-14.8%
0.00%
Q4 2018$1,000
-95.8%
812
-86.6%
0.00%
Q3 2018$24,0000.0%6,053
+41.1%
0.00%
Q2 2018$24,0004,2910.00%
Other shareholders
ONCOLYTICS BIOTECH INC shareholders Q3 2021
NameSharesValueWeighting ↓
Lynwood Capital Management Inc. 25,000$410.05%
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC 183,783$299,5660.03%
BRAVE ASSET MANAGEMENT INC 20,000$32,7720.01%
Newman Dignan & Sheerar, Inc. 18,915$30,8310.01%
Virtu Financial LLC 24,953$410.01%
Long Focus Capital Management, LLC 40,000$65,2000.00%
Cedar Mountain Advisors, LLC 5,651$9,2110.00%
Banque Cantonale Vaudoise 11,900$190.00%
SITTNER & NELSON, LLC 1,000$1,6390.00%
OSAIC HOLDINGS, INC. 8,332$13,0000.00%
View complete list of ONCOLYTICS BIOTECH INC shareholders